Approval · Notice of Compliance 38358 · 2026
METFORMIN TABLETS: Notice of Compliance 38358
Issued September 23, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38358
- Date
- September 23, 2026
- Company
- Granules India LimitedHyderabad, Telangana, India
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- GLUCOPHAGE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METFORMIN TABLETS | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per UNIT
- METFORMIN HYDROCHLORIDE 850 MG per UNIT